154 related articles for article (PubMed ID: 35662498)
21. Clinicopathological Features and Prognostic Outcomes of Papillary Renal Cell Carcinoma.
Qian X; Wan J; Qian C; Zhang J
Int J Gen Med; 2021; 14():7523-7531. PubMed ID: 34754225
[TBL] [Abstract][Full Text] [Related]
22. Comparative real-world survival outcomes of metastatic papillary and clear cell renal cell carcinoma treated with immunotherapy, targeted therapy, and combination therapy.
Riveros C; Ranganathan S; Xu J; Chang C; Kaushik D; Morgan M; Miles BJ; Muhammad T; Anis M; Aghazadeh M; Zhang J; Efstathiou E; Klaassen Z; Brooks MA; Rini B; Wallis CJD; Satkunasivam R
Urol Oncol; 2023 Mar; 41(3):150.e1-150.e9. PubMed ID: 36610815
[TBL] [Abstract][Full Text] [Related]
23. Prognostic Effect of Subclassification on Oncological Outcomes in Patients with Surgically Treated Localized Papillary Renal Cell Carcinoma: A Retrospective Propensity Score-matched Cohort Study.
Li S; Liu X; Chen X
J Cancer; 2022; 13(4):1193-1202. PubMed ID: 35281881
[No Abstract] [Full Text] [Related]
24. [Incidence and long-term prognosis of papillary renal cancer. Results of a retrospective multicenter study].
Waalkes S; Roos FC; Eggers H; Schumacher S; Janssen M; Wegener G; Thüroff JW; Hofmann R; Schrader M; Kuczyk MA; Schrader AJ;
Urologe A; 2011 Sep; 50(9):1125-9. PubMed ID: 21845424
[TBL] [Abstract][Full Text] [Related]
25. Survival analysis of 130 patients with papillary renal cell carcinoma: prognostic utility of type 1 and type 2 subclassification.
Pignot G; Elie C; Conquy S; Vieillefond A; Flam T; Zerbib M; Debré B; Amsellem-Ouazana D
Urology; 2007 Feb; 69(2):230-5. PubMed ID: 17275070
[TBL] [Abstract][Full Text] [Related]
26. Histological subtype of renal cell carcinoma significantly affects survival in the era of partial nephrectomy.
Nguyen DP; Vertosick EA; Corradi RB; Vilaseca A; Benfante NE; Touijer KA; Sjoberg DD; Russo P
Urol Oncol; 2016 Jun; 34(6):259.e1-8. PubMed ID: 26947350
[TBL] [Abstract][Full Text] [Related]
27. Oncological outcomes of surgery for isolated retroperitoneal recurrence in renal cancer patients after radical nephrectomy.
Staník M; Poprach A; Littnerová S; Čapák I; Hulová M; Šebová N; Lakomý R; Jarkovský J; Doležel J
Urol Oncol; 2022 Mar; 40(3):111.e27-111.e34. PubMed ID: 34961683
[TBL] [Abstract][Full Text] [Related]
28. Does the Unexpected Presence of Non-organ-confined Disease at Final Pathology Undermine Cancer Control in Patients with Clinical T1N0M0 Renal Cell Carcinoma Who Underwent Partial Nephrectomy?
Capitanio U; Stewart GD; Klatte T; Akdogan B; Roscigno M; Marszalek M; Dell'Oglio P; Zaffuto E; Rodriguez Faba O; Salagierski M; Lingard J; Carini M; Ouzaid I; Mir MC; Montorsi F; Da Pozzo LF; Stief C; Minervini A; Brookman-May SD
Eur Urol Focus; 2018 Dec; 4(6):972-977. PubMed ID: 28753867
[TBL] [Abstract][Full Text] [Related]
29. Simple enucleation versus radical nephrectomy in the treatment of pT1a and pT1b renal cell carcinoma.
Minervini A; Serni S; Tuccio A; Siena G; Vittori G; Masieri L; Giancane S; Lanciotti M; Khorrami S; Lapini A; Carini M
Ann Surg Oncol; 2012 Feb; 19(2):694-700. PubMed ID: 21861225
[TBL] [Abstract][Full Text] [Related]
30. Should patients with low-risk renal cell carcinoma be followed differently after nephron-sparing surgery vs radical nephrectomy?
Abu-Ghanem Y; Powles T; Capitanio U; Beisland C; Järvinen P; Stewart GD; Gudmundsson E; Lam TBL; Marconi L; Fernandéz-Pello S; Nisen H; Meijer RP; Volpe A; Ljungberg B; Klatte T; Bensalah K; Dabestani S; Bex A
BJU Int; 2021 Sep; 128(3):386-394. PubMed ID: 33794055
[TBL] [Abstract][Full Text] [Related]
31. Oncologic Outcomes of Partial Nephrectomy for Stage T3a Renal Cell Cancer.
Shvero A; Nativ O; Abu-Ghanem Y; Zilberman D; Zaher B; Levitt M; Fridman E; Portnoy O; Ramon J; Dotan ZA
Clin Genitourin Cancer; 2018 Jun; 16(3):e613-e617. PubMed ID: 29174471
[TBL] [Abstract][Full Text] [Related]
32. Renal fossa recurrence after nephrectomy for renal cell carcinoma: prognostic features and oncological outcomes.
Psutka SP; Heidenreich M; Boorjian SA; Bailey GC; Cheville JC; Stewart-Merrill SB; Lohse CM; Atwell TD; Costello BA; Leibovich BC; Thompson RH
BJU Int; 2017 Jan; 119(1):116-127. PubMed ID: 27489013
[TBL] [Abstract][Full Text] [Related]
33. High WHO/ISUP Grade and Unfavorable Architecture, Rather Than Typing of Papillary Renal Cell Carcinoma, May Be Associated With Worse Prognosis.
Yang C; Shuch B; Kluger H; Humphrey PA; Adeniran AJ
Am J Surg Pathol; 2020 May; 44(5):582-593. PubMed ID: 32101890
[TBL] [Abstract][Full Text] [Related]
34. [Papillary renal cell carcinoma: morphological subtypes, clinical and histopathological considerations].
Henry N; Rouach Y; Nguyen K; Verkarre V; Mejean A; Timsit MO
Prog Urol; 2010 Jun; 20(6):393-401. PubMed ID: 20538202
[TBL] [Abstract][Full Text] [Related]
35. Oncocytic papillary renal cell carcinoma: A clinicopathological and genetic analysis and indolent clinical course in 14 cases.
Han G; Yu W; Chu J; Liu Y; Jiang Y; Li Y; Zhang W
Pathol Res Pract; 2017 Jan; 213(1):1-6. PubMed ID: 27931799
[TBL] [Abstract][Full Text] [Related]
36. Accuracy of renal tumour biopsy for the diagnosis and subtyping of papillary renal cell carcinoma: analysis of paired biopsy and nephrectomy specimens with focus on discordant cases.
Prendeville S; Richard PO; Jewett MAS; Kachura JR; Sweet JM; van der Kwast TH; Cheung CC; Finelli A; Evans AJ
J Clin Pathol; 2019 May; 72(5):363-367. PubMed ID: 30755496
[TBL] [Abstract][Full Text] [Related]
37. Incidence and long-term prognosis of papillary renal cell carcinoma.
Schrader AJ; Rauer-Bruening S; Olbert PJ; Hegele A; Rustemeier J; Timmesfeld N; Varga Z; Hofmann R
J Cancer Res Clin Oncol; 2009 Jun; 135(6):799-805. PubMed ID: 19023595
[TBL] [Abstract][Full Text] [Related]
38. Prognostic implications of the magnetic resonance imaging appearance in papillary renal cell carcinoma.
Rosenkrantz AB; Sekhar A; Genega EM; Melamed J; Babb JS; Patel AD; Lo A; Najarian RM; Ahmed M; Pedrosa I
Eur Radiol; 2013 Feb; 23(2):579-87. PubMed ID: 22903703
[TBL] [Abstract][Full Text] [Related]
39. Partial versus radical nephrectomy in very elderly patients: a propensity score analysis of surgical, functional and oncologic outcomes (RESURGE project).
Mir MC; Pavan N; Capitanio U; Antonelli A; Derweesh I; Rodriguez-Faba O; Linares E; Takagi T; Rha KH; Fiori C; Maurer T; Zang C; Mottrie A; Umari P; Long JA; Fiard G; De Nunzio C; Tubaro A; Tracey AT; Ferro M; De Cobelli O; Micali S; Bevilacqua L; Torres J; Schips L; Castellucci R; Dobbs R; Quarto G; Bove P; Celia A; De Concilio B; Trombetta C; Silvestri T; Larcher A; Montorsi F; Palumbo C; Furlan M; Bindayi A; Hamilton Z; Breda A; Palou J; Aguilera A; Tanabe K; Raheem A; Amiel T; Yang B; Lima E; Crivellaro S; Perdona S; Gregorio C; Barbati G; Porpiglia F; Autorino R
World J Urol; 2020 Jan; 38(1):151-158. PubMed ID: 30937569
[TBL] [Abstract][Full Text] [Related]
40. Clinicopathological and immunohistochemical characteristics of papillary renal cell carcinoma with emphasis on subtyping.
Alomari AK; Nettey OS; Singh D; Kluger H; Adeniran AJ
Hum Pathol; 2015 Oct; 46(10):1418-26. PubMed ID: 26239624
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
